Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y Revenues

EarningsAuvelityPositive

AI Analysis

Summary

Axsome Therapeutics reported Q2 earnings that met estimates, with Auvelity generating year-over-year revenue growth. The company's lead commercial product is driving financial performance.

Outcome Details

Q2 earnings met estimates; Auvelity drove year-over-year revenue growth

Importance:4/10

Sentiment:

0.40

earningsrevenuecommercial_performanceAuvelity

Related Companies

$AXSM

Read the original article

Published by yahoo_finance on August 11, 2026 6:16 PM

Read Original